GlassScriptPhysician profile
Alexis Dunning
NPI 1780211862
$986.07
in general payments reported to CMS, 2019-2025
13 companies · $665 in 2025
The $665 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $9.93 · 2024: $311 · 2025: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $976.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $203.50 | 2024-2025 | Myosure Tissue Removal Device, Acessa Provu System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Abbvie INC. | $191.72 | 2024-2025 | |
| Organon LLC | $110.40 | 2022-2024 | |
| Biogen, INC. | $95.77 | 2025 | Zurzuvae |
| Shield Therapeutics INC | $73.35 | 2024 | |
| Exeltis, USA INC. | $68.40 | 2024-2025 | Slynd |
| Millicent US INC | $62.30 | 2025 | Intrarosa, Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $55.02 | 2025 | |
| Ethicon US, LLC | $40.32 | 2025 | Stratafix, Vistaseal |
| Exact Sciences Corporation | $26.70 | 2025 | The Cologuard Plus Collection Kit |
| Coopersurgical, INC. | $23.56 | 2025 | Paragard T 380a |
| Gynesonics, INC. | $17.94 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sumitomo Pharma America, INC. | $17.09 | 2024 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexis Dunning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.